TLR5 and neoplasm: To deepen our understanding of the role of TLR5 activation in tumor suppression, we examined the cytotoxic impact of spleen cells on MC-38 tumor cells following treatment with TLR5 agonist and anti-PD-1 (Supplementary Fig. 7).